Overview

NTM Info & Research helps accelerate medical research by funding or co-funding numerous studies related to NTM patient vulnerabilities, nontuberculous mycobacterial infection sources and treatments, and prevalence of the disease in the United States. In addition, NTMir assists on an ongoing basis with patient recruitment for clinical trials and studies. To make this process easier and faster, NTMir funded the creation of the NTM Patient Registry, as part of the COPD Foundation’s existing Bronchiectasis Registry.

Our Rapid Information Pilot Studies (RIPS)™ program funds short-term research in order to spur long-term investigative studies on issues of vital importance in the understanding, detection and treatment of pulmonary NTM disease. Each study is funded up to $50,000, and is completed in no more than 12 months. The results of these studies can then be used as a basis for funding of large scale, multi-centered investigations.

The objective of RIPS™ is to speed up the rate of investigations to provide new understandings of risk and treatment issues for pulmonary NTM patients.

Click here to learn more about completed studies.

Click here to learn more about the NTM Patient Registry and to find out how you can be registered.

Click here to read an article by Steven Holland, M.D. from the National Institutes of Health, on the importance of clinical trials and research.